• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Sanofi (SNY)

    -NYSE
    46.81 Dec 18, 4:02PM EST
    |Pre-Market : 46.08 Down 0.80 (1.71%) 9:10AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:46.81
    Open:N/A
    Bid:46.07 x 2000
    Ask:46.11 x 1000
    1y Target Est:52.83
    Beta:1.11
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:44.24 - 57.42
    Volume:0
    Avg Vol (3m):2,550,160
    Market Cap:122.84B
    P/E (ttm):24.47
    EPS (ttm):1.91
    Div & Yield:1.91 (4.20%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNY

    Comparison

    Symbol% ChgMkt Cap
    SNY 0.00%122.84B
    GSK104.07B
    MRK168.14B
    PFE201.43B

    Key Statistics

    Forward P/E (1 yr):14.40
    P/S (ttm):2.96
    Ex-Dividend Date:07-May-14

    Analysts

    Annual EPS Est (Dec-14) :3.19
    Quarterly EPS Est (Mar-14) :N/A
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):3.24

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sanofi discovers, develops, and distributes therapeutic solutions. Its primary products include Lantus and Apidra analogs of human insulin; Insuman insulin solutions and suspensions; Amaryl, a sulfonylurea; Lyxumia, a prandial GLP-1 receptor agoni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback